Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1) - Specific CD4+ T cell immunity to gag in HIV-1 - Infected individuals with differential disease progression: Reciprocal interferon-γ and interleukin-10 responses

Journal of Infectious Diseases

Volumn 184, Issue 10, 2001, Pages 1268-1278

  Ostrowski, Mario A ^a,b,d   Gu, Jenny X ^a   Kovacs, Colin ^a   Freedman, John ^a,b   Luscher, Mark A ^a   MacDonald, Kelly S ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10;

ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; T LYMPHOCYTE; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; VIRAL LOAD;

EID: 0035890108     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/324005     Document Type: Article

References (36)

1. -) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation
2. Immune control of HIV-1 after early treatment of acute infection
3. Characterization of HIV-1-specific T-helper cells in acute and chronic infection
4. + T cell responses associated with control of viremia
5. -) T cell responses
6. + T-cell induction and effector functions: A comparison of immunity against soluble antigens and viral infections
7. + T cells during the primary immune response to Epstein-Barr virus in vivo
8. Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection
9. + lymphocytes
10. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
11. - T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
12. - cell numbers and clinical staging
13. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals
14. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals
15. + T cell function during in vivo memory or tolerance induction
16. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity
17. + T cells
18. - T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
19. Interleukin-10
20. Immunological tolerance
21. The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines
22. Broadly distributed T cell reactivity, with no immunodominant loci, to the pre-erythrocytic antigen thrombospondin-related adhesive protein of Plasmodium falciparum in West Africans
23. Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy
24. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes
25. Co-stimulation of T cells results in distinct IL-10 and TNF-alpha cytokine profiles dependent on binding to ICAM-1, ICAM-2 or ICAM-3
26. Maturation of neonatal human CD4 T cells. III. Role of B7 co-stimulation at priming
27. - T cells and induce similar patterns of cytokine secretion in vitro
28. Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjogren's syndrome
29. Differential production of IL-10 by T cells and monocytes of HIV-infected individuals: Association of IL-10 production with CD28-mediated immune responsiveness
30. + T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease
31. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing
32. Immunoregulation in human lymphatic filariasis: The role of interleukin 10
33. Regulation of parasite antigen-driven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis
34. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients
35. Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum
36. Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming